GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medprin Regenerative Medical Technologies Co Ltd (SZSE:301033) » Definitions » Research & Development

Medprin Regenerative Medical Technologies Co (SZSE:301033) Research & Development : ¥26.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medprin Regenerative Medical Technologies Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medprin Regenerative Medical Technologies Co's Research & Development for the three months ended in Mar. 2024 was ¥5.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥26.4 Mil.


Medprin Regenerative Medical Technologies Co Research & Development Historical Data

The historical data trend for Medprin Regenerative Medical Technologies Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medprin Regenerative Medical Technologies Co Research & Development Chart

Medprin Regenerative Medical Technologies Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 18.21 16.28 25.88 30.61 26.78

Medprin Regenerative Medical Technologies Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.66 6.36 5.54 9.22 5.28

Medprin Regenerative Medical Technologies Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medprin Regenerative Medical Technologies Co  (SZSE:301033) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Medprin Regenerative Medical Technologies Co Research & Development Related Terms

Thank you for viewing the detailed overview of Medprin Regenerative Medical Technologies Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Medprin Regenerative Medical Technologies Co (SZSE:301033) Business Description

Traded in Other Exchanges
N/A
Address
No. 80 Lanyue Road, 3rd Floor, Area E, High-tech Industrial Development Zone, Guangdong Province, Science City, Guangzhou, CHN, 510663
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.

Medprin Regenerative Medical Technologies Co (SZSE:301033) Headlines

No Headlines